Phenomenex to be Acquired by Danaher Corporation
Phenomenex Inc. announced it has signed a definitive agreement to be acquired by Danaher Corporation. Phenomenex will operate as a standalone operating company, retaining the Phenomenex brand, its personnel and site locations.
"Phenomenex is a widely recognizable brand that we are proud to say is highly respected and well established as providing high-quality consumables to the scientific community worldwide," said Fasha Mahjoor, CEO, Phenomenex. "Joining Danaher will allow us to maintain the high pace of innovation that our customers and international distributors have come to expect from us. This is our opportunity to further expand our R&D activities, benefit our customers with a more diversified product portfolio and reinforce our market leadership."
"We are thrilled to have Phenomenex join Danaher's life sciences portfolio of businesses, which include SCIEX, Beckman Coulter Life Sciences, Pall, Leica Microsystems and Molecular Devices," said Dan Daniel, Executive Vice President, Danaher. "Phenomenex is a strong business characterized by high growth rates and margins and excellent growth prospects driven by increasing analytical testing needs in the health, research and environmental segments. The Danaher Business System (DBS) has a strong track record of helping businesses rapidly scale operations and create long-term customer value. We look forward to supporting the Phenomenex team in leveraging DBS tools for growth and welcoming them to our Life Sciences team."
The transaction, which is expected to close by late 2016, is subject to customary closing conditions and regulatory approvals.
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
The spontaneous and sophisticated side of self-assembly
Heraeus Noblelight Acquires Specialty Light Sources Company in the UK
Ovulation filmed from start to finish for the first time - New findings for fertility research
New blood test detects wide range of cancers - Test proved able to detect and indicate site of dozens of types of cancer with high accuracy
Gardner Denver Medical acquires ILS and Zinsser Analytic
Biotage AB and McMaster University sign joint agreement to develop new chemistry platform
‘Smart’ contact lenses could someday enable wireless glaucoma detection - Intelligent contact lens for quantitative intraocular pressure monitoring
Spectro Scientific acquired by AMETEK
Hach Lange announces name change
Trust in AI but not blindly - Artificial intelligence is sometimes met with scepticism but it has earned our trust
Nanotubes: cellular membranes on supply - Osmotic forces play a role in nanotube formation in cells